Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcutis Biotherapeutics (ARQT) Change in Intangibles (2024)

Arcutis Biotherapeutics (ARQT) has 1 years of Change in Intangibles data on record, last reported at $5.0 million in Q4 2024.

  • For Q4 2024, Change in Intangibles changed N/A year-over-year to $5.0 million; the TTM value through Dec 2025 reached $5.0 million, changed 0.0%, while the annual FY2025 figure was $10.0 million, 100.0% up from the prior year.
  • Change in Intangibles reached $5.0 million in Q4 2024 per ARQT's latest filing.
  • Across five years, Change in Intangibles topped out at $5.0 million in Q4 2024 and bottomed at $5.0 million in Q4 2024.